SEC 13F Intelligence

Bml Capital Management, LLC / STSAUSD

Bml Capital Management, LLC’s Satsuma Pharmaceuticals Inc Position

Does Bml Capital Management, LLC own Satsuma Pharmaceuticals Inc (STSAUSD)? Not currently — the last reported position was 6.44M shares worth $4M in Q1 2023; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$4M
Q1 2023
Shares
6.44M
% of Portfolio
+3.89%
Quarters Held
2
position exited

Position History STSAUSD

Reported value by quarter
Q4 ’22: $6MQ4 ’22Q1 ’23: $4MQ1 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20236.44M$4M+3.89%
Q4 20226.44M$6M+5.54%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Bml Capital Management, LLC’s full portfolio or all institutional holders of STSAUSD.